Trial
NCT02377362
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
GLWL Research Inc.
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
GLWL-01, Part A
Why stopped
Insufficient efficacy for this indication. The study stopped after Part B.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-21